Trial Profile
A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs BMS 641988 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 07 Aug 2009 Actual patient number changed from 6 to 7 as reported by ClinicalTrials.gov.
- 08 May 2009 Actual number of patients added as 6 as reported by ClinicalTrials.gov.
- 08 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.